Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
EBITDA Margin % is the ratio of EBITDA divided by net sales or Revenue. It is an performance metric measuring company's operating profitability. EBITDA Margin takes depreciation and amortization, interest expense and tax into account, which makes it easy to compare the relative profitability of companies of different sizes in the same industry.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
PT Selaras Citra Nusantara Perkasa Tbk Annual Data
Trend
EBITDA Margin %
PT Selaras Citra Nusantara Perkasa Tbk Semi-Annual Data
EBITDA Margin %
ISX:SCNP vs AAPL: EBITDA Margin % Comparison
For the Consumer Electronics subindustry, PT Selaras Citra Nusantara Perkasa Tbk's EBITDA Margin %, along with its competitors' market caps and EBITDA Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
PT Selaras Citra Nusantara Perkasa Tbk EBITDA Margin % vs Hardware Industry
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
PT Selaras Citra Nusantara Perkasa Tbk (ISX:SCNP) has a EBITDA Margin % of 0.00% as of . 20. EBITDA Margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent. View historical data on PT Selaras Citra Nusantara Perkasa Tbk and its competitors. According to the industry distribution chart, PT Selaras Citra Nusantara Perkasa Tbk ranks #999999 out of 2466 companies in the Hardware industry.
Is PT Selaras Citra Nusantara Perkasa Tbk's EBITDA Margin % too high?
PT Selaras Citra Nusantara Perkasa Tbk's current EBITDA Margin % is 0.00%. Based on the distribution chart, PT Selaras Citra Nusantara Perkasa Tbk ranks #999999 out of 2466 companies in the Hardware industry, which is in the bottom quartile relative to peers. Overall, PT Selaras Citra Nusantara Perkasa Tbk has a GF Score™ of 10/100, reflecting its overall financial health beyond just this single metric.
How does PT Selaras Citra Nusantara Perkasa Tbk's EBITDA Margin % compare to AAPL?
According to the Hardware industry distribution chart, PT Selaras Citra Nusantara Perkasa Tbk ranks #999999 out of 2466 companies for EBITDA Margin %. This places PT Selaras Citra Nusantara Perkasa Tbk in the lower half of its industry. The industry median EBITDA Margin % is 7.33. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EBITDA Margin % for a Hardware company?
The median EBITDA Margin % among Hardware companies is 7.33, based on 2,466 companies in the industry. Companies in the top quartile (top 25%) have a EBITDA Margin % significantly above this median, while those in the bottom quartile fall well below. However, EBITDA Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EBITDA Margin % mean?
A high EBITDA Margin % can signal that a stock is expensive relative to its fundamentals. EBITDA Margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent. View historical data on PT Selaras Citra Nusantara Perkasa Tbk and its competitors. For the Hardware industry, the median EBITDA Margin % is 7.33 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. PT Selaras Citra Nusantara Perkasa Tbk's current EBITDA Margin % is 0.00%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is PT Selaras Citra Nusantara Perkasa Tbk stock overvalued right now?
PT Selaras Citra Nusantara Perkasa Tbk (ISX:SCNP) has a current EBITDA Margin % of 0.00%. The current EBITDA Margin % is 0.00%. PT Selaras Citra Nusantara Perkasa Tbk's overall GF Score™ is 10/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EBITDA Margin % calculated?
EBITDA Margin % is calculated from a company's financial statements. For PT Selaras Citra Nusantara Perkasa Tbk (ISX:SCNP), the current EBITDA Margin % is 0.00% as of . 20. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
PT Selaras Citra Nusantara Perkasa Tbk is an equipment manufacturing company. Company's operations are classified into two main pillars: the household appliances manufacturing segment and the medical devices manufacturing segment. The company manufactures and sells its products under brands such as Turbo, Philips, Bissel, Holmes, and Oxone among others. It offers products like Electric Iron, Gas Stove, Electric Fan, Blender, and UVC Air Purifier among others. Company is developing a successful commercialization of flagship product, the Non-Invasive Vascular Analyzer (NIVA) products which are the foundation for the Company to develop and manufacture other medical diagnostic devices.
10GF Score
Get the complete analysis for ISX:SCNP
EBITDA Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
ISX:SCNP has been successfully added to your 
